Guidant Corp.

Recent Events

News & Analysis

guidant corp. and therapy - All News and Analysis

• Guidant to Expand Southern California Facilities; Drug Eluting and Carotid Stents, Emerging Therapies Drive Expansion

  - 2006-03-16

  SANTA CLARA, Calif. -- Guidant Corporation (NYSE:GDT) today announced that it will begin construction on expanded facilities in Temecula, Calif. The new facilities - including two buildings totaling approximately 300,000 square feet - will house additional operations and personnel dedicated to the company's drug eluting stent, endovascular and emerging technology...

  Tags: Guidant Corp., therapy

• Guidant Announces Updated and Positive Results of Real-World Carotid Artery Stenting Study; Results from 2,500 Patients Suggest Therapy Can Be Performed Safely by Broad Group of Physicians

  - 2006-03-14

  INDIANAPOLIS & ATLANTA -- Guidant Corporation (NYSE:GDT) today announced updated results of 2,500 patients enrolled in its post approval study of carotid artery stenting, called CAPTURE (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events). Results were presented today during the Late Breaking Registry Session at the American College of...

  Tags: Guidant Corp., patient, physician, therapy

• Guidant Announces Positive Preliminary Results of Large Real-World Carotid Artery Stenting Study; Study Suggests Therapy Can Be Performed Safely by Broad Group of Physicians

  - 2005-10-20

  INDIANAPOLIS & WASHINGTON -- Guidant Corporation (NYSE:GDT) today announced preliminary results of its study of carotid artery stenting in high-risk patients, called CAPTURE (Carotid ACCULINK/ACCUNET Post Approval Trial to Uncover Rare Events). Results were presented today during the Late Breaking Registry Session at the Transcatheter Cardiovascular Therapeutics meeting in Washington,...

  Tags: Guidant Corp., physician, therapy

• Guidant Receives Exclusive Expanded Indication for Heart Failure Treatment; Thousands of Additional Patients Now Eligible to Receive Cardiac Resynchronization Therapy Defibrillators

  - 2004-09-15

  INDIANAPOLIS & ST. PAUL, Minn. -- Guidant Corporation (NYSE:GDT) today announced that the U.S. Food and Drug Administration FDA has approved an expanded indication for the company's portfolio of cardiac resynchronization therapy defibrillators (CRT-D). The expanded indication makes Guidant's cardiac resynchronization therapy defibrillators available to thousands more heart failure patients,...

  Tags: Guidant Corp., patient, therapy

• Guidant Receives First U.S. Approval for New Therapy Designed to Reduce Risk of Stroke; New Carotid Stent System Offers Minimally Invasive Alternative to Open Surgery

  - 2004-08-31

  INDIANAPOLIS & SANTA CLARA, Calif. -- Guidant Corporation (NYSE:GDT) today announced U.S. Food and Drug Administration FDA approval of a new carotid stent system designed to reduce the risk of stroke associated with carotid artery disease. The RX ACCULINKTM Carotid Stent System and RX ACCUNETTM Embolic Protection System will provide...

  Tags: FDA, Guidant Corp., therapy

• Guidant Sponsors Biological Pacemaker Research with Columbia and Stony Brook Universities; Collaboration Explores Advanced Applications for Gene Therapy to Benefit Heart Patients

  - 2004-08-26

  INDIANAPOLIS & ST. PAUL, Minn. -- Guidant Corporation (NYSE:GDT) today announced a collaboration with Columbia University Medical Center and Stony Brook University to study a new gene therapy that may ultimately provide a better understanding of how genetically engineered cells can help pace the heart. This five-year, phased investment will...

  Tags: benefit, collaboration, Guidant Corp., therapy

• Guidant to Collaborate With Miravant on Development of Innovative Therapy for Potential Vulnerable Plaque Applications

  - 2004-07-06

  INDIANAPOLIS & SANTA CLARA, Calif. -- Company Makes Staged Equity Investment in Miravant Medical Technologies

  Tags: Guidant Corp., therapy

• Guidant Announces Results of Key Study In Emerging Field of Heart Attack Prevention; Vulnerable Plaque Presents Significant Opportunity for Preventive Therapy

  - 2002-09-27

  Business Editors/Health and Medical Writers

  Tags: Guidant Corp., therapy

• Guidant Supports MayoClinic.com in Heart Disease Education - Relationship Advances Efforts to Increase Patient Awareness of Disease and Therapies

  - 2002-06-20

  Business Editors, Health/Medical Writers

  Tags: Guidant Corp., patient, therapy

• Guidant Introduces New Therapy for Treating Postoperative Atrial Fibrillation; New Option Allows Early Intervention of Common Complication

  - 2002-05-29

  Business Editors and Health/Medical Writers

  Tags: Guidant Corp., therapy